FDA — authorised 13 February 2018
- Application: NDA208470
- Marketing authorisation holder: MILLICENT
- Indication: Labeling
- Status: approved
🇺🇸 Intrarosa in United States
FDA authorised Intrarosa on 13 February 2018
Marketing authorisation
Intrarosa in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in United States
Frequently asked questions
Is Intrarosa approved in United States?
Yes. FDA authorised it on 13 February 2018.
Who is the marketing authorisation holder for Intrarosa in United States?
MILLICENT holds the US marketing authorisation.